Friday,
July 11, 2003
The National Cancer Institute (NCI) announced its intention to create a
cancer-based biomedical informatics network, called the Cancer Biomedical
Informatics Grid (caBIG).
learn more..
Monday, July 26, 2004
The C3 Bioinformatics Group Website prototype is created to establish a web
presence in support of the groups activities and development efforts.
Dr. Stephen Qualman, Director of Laboratories, also serves as the Director of
the Center for Childhood Cancer.
“Establishment of the C3 Informatics Group will ensure continued strategic
Divisional focus on information management.”
Dave Billiter, Development Manager.
The Group will contribute to the development, management and promotion of
effective practices in collection, storage, management, analysis and reporting
of information about services funded by the Department. It will assist program
areas in the Division and agencies funded by the Department to define their data
requirements and develop data standards; promoting the value of sound
information management principles and practices to support business activities.
It will perform a critical role in planning and coordinating delivery of
information management projects.
Prognostic Factors and Clinical Outcomes in Children and Adolescents With
Metastatic Rhabdomyosarcoma--A Report From the Intergroup Rhabdomyosarcoma Study
IV
learn more..
The cancers that attack
children are different from the principal cancers of adults.
Children frequently have a more advanced stage of cancer when they are first
diagnosed. Only about 20% of adults with cancer show evidence that the disease
has spread at the time of diagnosis, yet 80% of the children who are diagnosed
with cancer have disease which has already spread to distant sites in the body.
Most adult cancers result from lifestyle factors, such as smoking, diet,
occupation, and other prolonged exposure to cancer-causing agents. The causes of
most childhood cancers are not yet known.
caBig Web Cast
The cancer Biomedical Informatics Grid - caBIG: Advancing the Promise of
Molecular Medicine.
